Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/9/2025

Target Testosterone Level in Testosterone Replacement Therapy (TRT)

  • The American Urological Association (AUA) recommends targeting a total testosterone level in the middle tertile of the normal reference range (450-600 ng/dL) as the goal for testosterone replacement therapy 1
  • The goal of testosterone therapy is the normalization of total testosterone levels combined with improvement in symptoms or signs 1

Monitoring Recommendations

  • Testosterone levels should be tested 2-3 months after treatment initiation and/or after any dose change to ensure target levels are being achieved 2
  • Once stable levels are confirmed on a given dose, monitoring every 6-12 months is typically sufficient 2
  • For injectable testosterone: measure levels midway between injections, targeting a mid-normal value (500-600 ng/dL) 2
  • For transdermal preparations: levels can be measured at any time, with the understanding that peak values occur 6-8 hours after application 2

Clinical Considerations

  • Treatment programs should use the minimal dosing necessary to drive testosterone levels to the normal physiologic range of 450-600 ng/dL 1
  • If patients do not experience symptomatic relief after reaching the specified target testosterone levels, or remain testosterone deficient despite symptom improvement, testosterone therapy should be stopped 1

Safety Considerations

  • Exogenous testosterone therapy should not be prescribed to men who are currently trying to conceive, as it can interrupt normal spermatogenesis 1
  • Testosterone therapy should not be commenced for a period of three to six months in patients with a history of cardiovascular events 1
  • Alkylated oral testosterone should not be prescribed due to potential liver toxicity 1
  • Patients on testosterone therapy should be advised to report any possible cardiovascular symptoms during routine follow-up visits 1
  • The FDA has required labeling to inform healthcare professionals and patients of a possible increased risk of heart attack and stroke with testosterone preparations used to treat age-related hypogonadism 2

Formulation Considerations

  • Transdermal testosterone preparations (gel, patch) are often favored over intramuscular injections due to the relative stability of day-to-day testosterone levels 2
  • Injectable testosterone may be associated with greater fluctuations in testosterone levels, with peaks and valleys between injections 2

Testosterone Levels in Adult Males

Reference Ranges and Age-Specific Considerations

  • The American Urological Association defines a testosterone level below 300 ng/dL as a reasonable cut-off to support the diagnosis of low testosterone across all adult age groups 3
  • The normal range for testosterone in adult men is generally considered to be 300-800 ng/dL in most laboratories 4

Measurement Considerations

  • The diagnosis of low testosterone should only be made after two total testosterone measurements are taken on separate occasions, with both conducted in an early morning fashion 3
  • Morning measurements are critical as testosterone levels naturally fluctuate throughout the day, with highest levels typically occurring in the morning 3
  • Fasting morning testosterone levels provide the most accurate assessment 5, 6
  • Only 13 clinical trials in a comprehensive review required 2 fasting morning testosterone levels for accurate diagnosis 6

Clinical Implications of Testosterone Levels

  • Testosterone deficiency in males is associated with energy imbalance, impaired glucose control, reduced insulin sensitivity, dyslipidemia, increased abdominal fat mass, and reduced lean body mass 4
  • Low testosterone levels can affect sexual function, with studies showing that testosterone treatment improves sexual function in men with low levels 7, 8
  • When evaluating low total testosterone clinically in a man with obesity, measurement of morning serum free testosterone is essential, as obesity can affect sex hormone-binding globulin levels 4

Common Pitfalls in Testosterone Assessment

  • Many men receive testosterone therapy without proper diagnosis - studies estimate that up to 25% of men who receive testosterone therapy do not meet the criteria to be diagnosed as testosterone deficient 3
  • Nearly half of men placed on testosterone therapy do not have their testosterone levels checked after therapy commences 3

Monitoring Testosterone Therapy

  • For men on testosterone therapy, the target trough testosterone level should be maintained within the physiological range of 300-1,000 ng/dL 9

Testosterone Levels and Treatment in Adult Men

Diagnostic Considerations

  • It's essential to recognize that testosterone levels naturally decline with age, but this doesn't automatically indicate pathology requiring treatment, as noted by the Annals of Internal Medicine 10
  • Morning measurements are essential because testosterone levels fluctuate throughout the day, with peak levels occurring in the morning, according to the Annals of Internal Medicine 10

Treatment Thresholds

  • The Princeton III Consensus and multiple international societies agree that testosterone >350 ng/dL typically does not require replacement therapy 11
  • Testosterone <230 ng/dL usually benefits from testosterone replacement therapy in symptomatic men, as recommended by the Princeton III Consensus and multiple international societies 11
  • Testosterone 231-346 ng/dL represents a gray zone where a 4-6 month trial may be considered in symptomatic men after careful risk-benefit discussion, according to the Princeton III Consensus and multiple international societies 11

Testosterone Treatment Threshold

Diagnostic Criteria

  • The presence of hypogonadal symptoms, including decreased libido, decreased spontaneous erections, erectile dysfunction, decreased physical stamina and strength, depressed mood, fatigue, increased visceral adiposity, sleep disturbance, and poor concentration/memory, is required for testosterone replacement therapy in men with low testosterone levels 12, 13
  • Physical findings, such as testicular or muscle atrophy, may also be present in men with hypogonadism 12, 13

Treatment Considerations

  • The American Urological Association and other guideline societies recommend against initiating testosterone therapy in eugonadal individuals, with the European Association of Urology explicitly stating this recommendation 14, 15
  • Approximately 20% of men who had their testosterone level measured before initiating therapy had a level above 300 ng/dL, highlighting the importance of proper diagnosis before starting treatment 14, 15
  • Up to 25% of men receiving testosterone therapy do not meet diagnostic criteria for testosterone deficiency, emphasizing the need for careful patient selection 14, 15

Cardiovascular Risk

  • Low testosterone levels have been associated with increased all-cause and cardiovascular mortality in multiple prospective studies, with hazard ratios ranging from 1.24 to 7.1 12, 13

Testosterone Level Diagnosis and Treatment

Diagnostic Considerations

  • The American Urological Association is not cited, however, the Annals of Internal Medicine suggests that proper diagnosis requires two separate fasting morning testosterone measurements, not a single random test, with both measurements obtained in the early morning when testosterone levels peak naturally 16
  • Testosterone levels above 350 ng/dL typically do not require replacement therapy, according to the Mayo Clinic Proceedings 17
  • Testosterone levels below 230 ng/dL usually benefit from testosterone replacement therapy in symptomatic men, as stated by the Mayo Clinic Proceedings 17
  • The Mayo Clinic Proceedings also notes that testosterone levels between 231-346 ng/dL are in a gray zone where a 4-6 month trial may be considered in symptomatic men after careful risk-benefit discussion 17

Treatment Thresholds and Symptoms

  • The Mayo Clinic Proceedings recommends that treatment decisions should consider symptoms, including decreased libido, decreased spontaneous erections or erectile dysfunction, and depressed mood and fatigue, in addition to testosterone levels 17
  • The Mayo Clinic Proceedings also suggests that increased visceral adiposity is a symptom that may be considered for treatment, in addition to low testosterone levels 17

Target Testosterone Levels After Initiating TRT

Target Ranges for Monitoring

  • Free testosterone measurement by equilibrium dialysis is essential when evaluating borderline total testosterone levels, particularly in men with obesity or diabetes where low sex hormone-binding globulin may artificially lower total testosterone, as suggested by research in the field of Gastroenterology 18

Clinical Response Considerations

  • Note: There are no other cited facts in the article that meet the specified criteria.

REFERENCES

9

Target Trough Testosterone Levels for Trans Men [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025